Many organizations currently provide funding for priority systematic reviews. These include research funding agencies, those organizations that provide or fund healthcare services, those responsible for health technology assessment and those involved in the development of clinical practice guidelines.
The Collaboration has a policy that neither the preparation of Cochrane reviews nor infrastructure costs of CRGs can be funded through a commercial source or agency with a vested interest in the review (see Section 2.6).